Scientists discover more efficient gene-editing tool for treating diseases

The landscape of medicine is undergoing a revolution as researchers move beyond traditional CRISPR-Cas9 technology.

In 2025 and 2026, scientists unveiled next-generation tools like Bridge Editing, STITCHR, and retron-based systems.

Unlike early CRISPR methods that primarily focused on small DNA deletions, these modern techniques allow for the safe insertion and replacement of large gene sequences.

Bridge Editing, for example, mimics bacterial "jumping genes" to link DNA strands directly, while STITCHR uses RNA to provide a one-and-done solution for replacing faulty genes.

Furthermore, AI platforms like CRISPR-GPT are acting as intelligent copilots, speeding up experimental design.

While the 2023 approval of Casgevy marked a milestone, the industry is now focused on making these treatments scalable and safer.